2-26473159-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000272371.7(OTOF):āc.3706C>Gā(p.Arg1236Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00097 in 1,612,702 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1236H) has been classified as Likely benign.
Frequency
Consequence
ENST00000272371.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194248.3 | c.3706C>G | p.Arg1236Gly | missense_variant | 29/47 | ENST00000272371.7 | NP_919224.1 | |
OTOF | NM_194323.3 | c.1465C>G | p.Arg489Gly | missense_variant | 12/29 | ENST00000339598.8 | NP_919304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.3706C>G | p.Arg1236Gly | missense_variant | 29/47 | 1 | NM_194248.3 | ENSP00000272371 | A1 | |
OTOF | ENST00000339598.8 | c.1465C>G | p.Arg489Gly | missense_variant | 12/29 | 1 | NM_194323.3 | ENSP00000344521 |
Frequencies
GnomAD3 genomes AF: 0.000644 AC: 98AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000590 AC: 147AN: 249240Hom.: 0 AF XY: 0.000599 AC XY: 81AN XY: 135298
GnomAD4 exome AF: 0.00100 AC: 1467AN: 1460510Hom.: 1 Cov.: 33 AF XY: 0.000962 AC XY: 699AN XY: 726564
GnomAD4 genome AF: 0.000644 AC: 98AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.000673 AC XY: 50AN XY: 74326
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 9 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Feb 02, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3C. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with auditory neuropathy, autosomal recessive 1, and deafness, autosomal recessive 9 (MIM#601071). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to glycine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (161 heterozygotes, 0 homozygotes). (SP) 0309 - Alternative amino acid changes at the same position has been observed in gnomAD (v2) (highest allele count: 13 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0809 - Previous evidence of pathogenicity for this variant is inconclusive. This variant has been reported as a VUS multiple times in the ClinVar database. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 21, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 18, 2023 | Observed homozygous in an individual referred for genetic testing at GeneDx who had a different genetic etiology for the phenotype; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 01, 2018 | Variant classified as Uncertain Significance - Favor Benign. The p.Arg1236Gly va riant in OTOF has been previously reported by our laboratory in two individuals with hearing loss, neither of whom had a second variant on the other allele. It has also been identified in 0.12% (12/10110) of Ashkenazi Jewish and 0.09% (111/ 125738) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Co mputational prediction tools and conservation analysis do not provide strong sup port for or against an impact to the protein. In summary, while the clinical sig nificance of the p.Arg1236Gly variant is uncertain, its frequency suggests that it is more likely to be benign. ACMG/AMP criteria applied: BS1_Supporting. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.3706C>G (p.R1236G) alteration is located in exon 29 (coding exon 29) of the OTOF gene. This alteration results from a C to G substitution at nucleotide position 3706, causing the arginine (R) at amino acid position 1236 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at